📣 Participate now in the global Liver Health Super Shaper Award to honor medical professionals for their exceptional contributions to enhancing the lives of patients with chronic liver disease. Two winners, chosen by a global panel, will have the opportunity to donate $10,000 dollars to a health charity of their choice. ➡️ Nominate a colleague who deserves recognition today: https://lnkd.in/gYF2MyjA #LiverHealthMatters #FibroScan
Echosens
Équipements médicaux
Paris, Île-de-France 17 120 abonnés
Nous façonnons le futur de la santé du foie. Because liver health matters
À propos
Pionnier dans son domaine, Echosens a modifié considérablement la pratique du diagnostic des maladies du foie avec FibroScan®, la solution non invasive de référence pour une prise en charge globale de la santé du foie. FibroScan® est reconnu dans le monde entier comme l’outil de référence pour l'évaluation de la fibrose et de la stéatose hépatiques avec plus de 4 200 publications soumises à des comités de lecture et plus de 180 recommandations internationales. Echosens distribue FibroScan® dans plus de 100 pays, permettant ainsi la réalisation de millions d'examens du foie dans le monde entier.
- Site web
-
http://www.echosens.com
Lien externe pour Echosens
- Secteur
- Équipements médicaux
- Taille de l’entreprise
- 201-500 employés
- Siège social
- Paris, Île-de-France
- Type
- Société civile/Société commerciale/Autres types de sociétés
- Fondée en
- 2001
- Domaines
- Diagnostic non-invasif en hépatologie, Pionnier en Elastographie quantitative et Evaluation de la fibrose hépatique et de la cirrhose
Lieux
Employés chez Echosens
Nouvelles
-
We're delighted to be a partner of the European Liver Screening Week, organized by the European Liver Patients' Association - ELPA. Get your #liver screened for free on the Esplanade of the European Parliament in Brussels, from September 30 to October 4, and learn how to take care of your liver's health. #LiverHealthMatters #EuropeanLiverScreeningWeek
BREAKING NEWS! We are honored that Roberta Metsola President of the European Parliament, 🇪🇺 🏛️✨ has granted the European Parliament’s #patronage to #EuropeanLiverScreeningWeek! 🏛️ 🇪🇺 Take a moment for yourself—get your liver screened for #FREE and learn how you can protect your health! Join us in the heart of Brussels! 🗓️ Date: September 30 – October 4, 2024 📍 Location: Esplanade of the European Parliament, Brussels ⏰ Time: 9:30 AM to 5:30 PM daily With the support of President Metsola** and the European Parliament, we’re on a mission to promote #liver health and offer life-saving screenings. Don’t miss out—be part of a healthier future! 👩⚕️👨⚕️ #EuropeanLiverScreeningWeek October #LiverCancerAwarenessMonth #RobertaMetsola #EuropeanParliament #LiverHealth #FreeScreening #LiverAwareness #HealthForAll #TakeCareOfYourLiver #EUCancerPlan #LiverCancer #MASH #MASLD #NCDs #obesity #hepatitis #Alcohol #RareLiverDiseases European Commission EU Health and Food Safety European Health and Digital Executive Agency (HaDEA) WHO Regional Office for Europe World Health Organization EASL the home of Hepatology International Liver Cancer Association (ILCA) UEG - United European Gastroenterology Union for International Cancer Control (UICC) European Centre for Disease Prevention and Control (ECDC) European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) European Cancer Organisation Cancer Patients Europe - CPE PFMD .org Digestive Cancers Europe European Association for the Study of Obesity (EASO) IARC - International Agency for Research on Cancer / World Health Organization International Diabetes Federation Europe International Diabetes Federation Aleksander Krag Debbie Shawcross Ben Hainsworth Manuel Romero Gomez Shaibu Issa Nicholas Brooke Marco Greco Marko Korenjak Antonella Cardone Veronika Všetíčková Beatrice Credi MSc Milan Mishkovikj, M.A. Fédération SOS Hépatites & Maladies du foie Anastassiya Semeiskaya European Centre for Disease Prevention and Control (ECDC) Maya Matthews Katie Owens Robb Butler ESMO - European Society for Medical Oncology
-
⏰ Heute ist es soweit! Nehmen Sie heute Abend an unserem #Webinar mit BODYMED GmbH zum Thema Lebergesundheit und Stoffwechselerkrankungen teil : Gesund ist und bleibt man nur mit einer gesunden Leber mit Dr. Hardy Walle, Dr. Nikolaus Scheper und Andrey Popovich. 👉 Erfahren Sie mehr über die neuesten Empfehlungen in der #Diabetologie sowie über reale, alltägliche klinische Fälle. 📍Anmelden: https://lnkd.in/eiuvYWg5
-
⏰ Happening today! Don't miss our masterclass on Guided VCTE™ – our latest and patented technology available on the next generation #FibroScan. In this #webinar learn about how this technology can impact both the operator and physician experience, with a focus on optimizing liver health management through efficiency and standardization. 📍 Join us today : https://lnkd.in/e2sq83Fd Louise Campbell MSc (AP), RMN, RN, FRCP Raj Vuppalanchi #LiverHealthMatters
-
🔍 Dr. Mazen Noureddin, MD, MHSc shares insights on the role of FibroScan® in evaluating if Rezdiffra™ is right for patients (via Healio): “The first step in considering Rezdiffra is you need to confirm that the patient has metabolic dysfunction-associated steatotic liver disease. This is usually done by steatosis assessment via ultrasound or FibroScan and ruling out all other causes of liver disease, in particular alcohol-related liver disease as well as autoimmune hepatitis. The next step is to tease out if the patient has significant and advanced fibrosis. At the same time, we are ruling out cirrhosis using noninvasive tests.” Read more 👉 https://lnkd.in/gzJawQNt
-
Echosens partners with the Barcelona Institute for Global Health (ISGlobal), to promote and support “MASLD and MASH: Prioritizing a global public health threat”, a liver health event, with panel discussions by experts such as Prof. Jeffrey V. Lazarus, Dr Arun Sanyal, Johanna Ralston and Christoph Benn, on the sidelines of the United Nations General Assembly (UNGA) on September 23 in New York.
Join the conversation on liver health policy at the "MASLD and MASH: prioritising a global public health threat" event supported by #ISGlobal on 23 September in New York. You will have the chance to listen to an insightful discussion with 4 expert panellists, including: 🔸Jeffrey V. Lazarus, Professor of Global Health, CUNY Graduate School of Public Health and Health Policy 🔸Johanna Ralston, CEO, World Obesity Federation 🔸Arun Sanyal, Director, VCU Stravitz-Sanyal Institute for Liver Disease and Metabolic Health, Virginia Commonwealth University School of Medicine 🔸Christoph Benn, Director for Global Health Diplomacy, Joep Lange Institute For more information about the event, including registration and agenda, visit our web: 🔗https://lnkd.in/dpwcKUQs The event is supported financially by Novo Nordisk, Boehringer Ingelheim, Echosens and CUNY Graduate School of Public Health and Health Policy.
-
🔹 Are you inspired by a colleague's commitment to liver health? 🔹 Know someone committed to helping change patient lives? 🔹 Is there a liver health advocate you admire? The inaugural Liver Health Super Shaper award is a tribute to the dedication and groundbreaking work of medical professionals in the battle against chronic liver disease. Two remarkable winners will be honored with not just recognition, but also a unique opportunity: the chance to direct a $10,000 donation to a health charity close to their hearts, courtesy of Echosens. 👉 Nominate your liver health hero today: https://lnkd.in/gYF2MyjA Together, we can spotlight the extraordinary efforts that are transforming patient care in liver health. #LiverHealthMatters #FibroScan
-
📺 No te pierdas nuestro próximo #webinar el 19 de septiembre a las 20:30h : Importancia de un enfoque multidisciplinar para el abordaje de la #EHmet, de las guías a la práctica clínica con el Dr. Jose Altamirano MD MSc y el Dr. CRISTOBAL MORALES. Presentarán las últimas recomendaciones sobre el manejo de los pacientes con EHmet, como parte de un abordaje multidisciplinar. Ambos compartirán su experiencia. 📍 Únete a nosotros : https://lnkd.in/eFPTqBH5 #LiverHealthMatters
-
📺 Verpassen Sie nicht unser nächstes #Webinar, das gemeinsam mit BODYMED GmbH am 25. September um 19 Uhr veranstaltet wird: Gesund ist und bleibt man nur mit einer gesunden Leber mit Dr. Hardy Walle, Dr. Med. Nikolaus Scheper und Andrey Popovich. Sie werden die Zusammenhänge zwischen Stoffwechselerkrankungen und Lebererkrankungen erläutern: Ursachen von Fettleber und Leberfibrose. Sie werden auch die verfügbaren Diagnoseinstrumente wie #FibroScan vorstellen, um schließlich ihre Erfahrungen über den Alltag in einer auf #Diabetologie spezialisierten Praxis zu teilen. 📍 Schließen Sie sich uns an : https://lnkd.in/eiuvYWg5 #LiverHealthMatters
-
🎙️ Don’t miss our latest podcast episode of Liver Health Shaper! Join two of the leading voices in liver health, Dr. Naim Alkhouri, MD, FAASLD, Chief Medical Officer at Arizona Liver Health , and Dr. Mazen Noureddin, MD, MHSc, Professor of Medicine and Director of the Houston Research Institute , as they discuss: 🔸The historic new treatment for MASH – Rezdiffra™ – and what it means for patients 🔸Navigating prior authorization for Rezdiffra™ 🔸The impact of FibroScan® with Guided VCTE™ technology and the new Liver Health Management platform 🎧 Listen here 👉 https://lnkd.in/eWQE7S7u #LiverHealthMatters #MASH #FibroScan #Rezdiffra